טוען...
Benzodiazepine receptor quantification in Huntington's disease with [(123)I]iomazenil and SPECT
OBJECTIVES—Increasing evidence suggests that metabolic changes predate neuronal death in Huntington's disease and emission tomography methods (PET and SPECT) have shown changes in glucose consumption and receptor function in early and possibly even presymptomatic disease. Because the GABA(A)-be...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2001
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1737353/ https://ncbi.nlm.nih.gov/pubmed/11309461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.70.5.657 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|